Susan E. Barrowcliffe, General Manager, Europe at Aimmune Therapeutics, Inc. (AIMT), sold 15,167 shares at $22.00 ($334K) on 2017-09-06, disclosed to the SEC on 2017-09-07.
Open-market sale of $334k AIMT by General Manager, Europe. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AIMT | SELL | 2018-01-04 | $5.6M | — | Filing → |
| AIMT | SELL | 2017-09-27 | $500K | — | Filing → |
| AIMT | SELL | 2017-09-07 | $405K | — | Filing → |